This study from Shanghai is a retrospective review of 142 patients presenting to an ENT hospital with deep neck infections (DNIs). The findings of the study are comparable to many of the previous studies, however the authors found tonsillitis and...
Ultrasound-guided fine needle aspiration cytology (USFNAC) when applied as initial investigation often proves non-diagnostic, the incidence being as high as 50% in a recent audit. In this study, the authors applied ultrasound-guided core biopsy (USCB) to neck lumps over 1cm...
When The Chocolate Line in Bruges, Belgium, was approached by the charity, Shout at Cancer, there was always going to be something very special and innovative in the pipeline! Shout at Cancer’s Thomas Moors has been chatting with Julius Persoone,...
There are at least 15 countries now running genome sequencing projects. The team in Manchester, UK, and Boston, USA, share their SEQaBOO project. Abstract SEQaBOO (SEQuencing a Baby for an Optimal Outcome) will transform newborn hearing screening (NBHS) by bringing...
1 March 2017
| Vasant Oswal, Dhananjay Kelkar, Sachin Gandhi, Salim Nazir, Paul O’Flynn (Prof)
|
ENTA - ENT
In 2001, a non-profit healthcare facility was founded in Pune India, providing low and middle income group patients with treatment, not only at a minimum cost, but of a quality which bears the stamp of approval by the Royal College...
Whilst there are various therapeutic options for ameliorating the impact of tinnitus, there is no current approved treatment for attempting to eradicate, or even for reducing, the loudness of tinnitus.
When Richard Irving and Ann-Louise McDermott made their successful bid to host BACO 2020 in Birmingham, they knew it had far more going for it than the International Conference Centre! Lucy Dalton tells us a little more about the attractions...
Professor Bill Gibson is one of the great pioneers of inner ear surgery and the recent publication of his biography is a reflection of his remarkable life and career. Bill Gibson: Pioneering Bionic Ear Surgeon will be enjoyed by everyone...
BIOHIT HealthCare is pleased to announce its partnership with Celltrion Healthcare UK Ltd, providing point-of-care assays for the Celltrion Connect Dedicated Homecare Service, which is designed to seamlessly support patients with inflammatory bowel disease (IBD) and their healthcare providers.
BIOHIT HealthCare Ltd will be attending the upcoming BSG Live 2023 conference in Liverpool, where it will unveil a revolutionary new test to support decision making for gastroscopy referrals and improve the early detection of gastric cancer.
Many of us were told as children that we would get square eyes from watching too much television. But spare a thought for those late Victorian ladies, embracing their first taste of liberty on a bicycle, who were threatened with...